par Olazagoitia-Garmendia, Ane;Rojas-Márquez, Henar;Trobisch, Tim;Moreno-Castro, Cristina;Rodriguez Etxebarria, Ariadne;Mentxaka, Jon;Tripathi, Ajai;Yang, Bibo;Martin Ruiz, Itziar;Anguita, Juan;Meana, J․ Javier;Ding, Yiliang;Dutta, Ranjan;Schirmer, Lucas;Igoillo Esteve, Mariana
;Santin, Izortze;Castellanos-Rubio, Ainara
Référence Molecular Therapy Nucleic Acids, 36, 2, 102533
Publication Publié, 2025-06-01

Référence Molecular Therapy Nucleic Acids, 36, 2, 102533
Publication Publié, 2025-06-01
Article révisé par les pairs
Titre: |
|
Auteur: | Olazagoitia-Garmendia, Ane; Rojas-Márquez, Henar; Trobisch, Tim; Moreno-Castro, Cristina; Rodriguez Etxebarria, Ariadne; Mentxaka, Jon; Tripathi, Ajai; Yang, Bibo; Martin Ruiz, Itziar; Anguita, Juan; Meana, J․ Javier; Ding, Yiliang; Dutta, Ranjan; Schirmer, Lucas; Igoillo Esteve, Mariana; Santin, Izortze; Castellanos-Rubio, Ainara |
Informations sur la publication: | Molecular Therapy Nucleic Acids, 36, 2, 102533 |
Statut de publication: | Publié, 2025-06-01 |
Sujet CREF: | Pharmacologie |
Psychiatrie | |
Mots-clés: | brain |
cell-specificity | |
lncRNA | |
metabolism | |
mitochondria | |
MT: non-coding RNAs | |
multiple sclerosis | |
neuroinflammation | |
RNA modification | |
SNP | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:2162-2531 |
info:doi/10.1016/j.omtn.2025.102533 | |
info:pii/S2162253125000873 | |
info:scp/105002872827 |